Organon & Co.
OGN· NYSE
OGNOrganon & Co.
Filed Aug 16, 2021 · 10-Q · 47 days after period end · 0001821825-21-000009
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $1.60B | $1.53B |
| Net Income | $427.00M | $542.00M |
| EPS Diluted | $1.68 | $2.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end
